If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Paolo Pronzato is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 21 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Fluorouracil Medicine & Life Sciences
Cyclophosphamide Medicine & Life Sciences
Granulocyte Colony-Stimulating Factor Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1984 2019

  • 4971 Citations
  • 29 h-Index
  • 192 Article

Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events

Grisanti, S., Bianchi, S., Locati, L. D., Triggiani, L., Vecchio, S., Bonetta, A., Bergamini, C., Conte, P., Airoldi, M., Merlano, M., Carlini, P., Ibrahim, T., Rossetto, C., Alfieri, S., Pronzato, P., Tonoli, S., Maroldi, R., Nicolai, P., Resteghini, C., Magrini, S. M. & 1 others, Berruti, A., Mar 1 2019, In : PLoS One. 14, 3, e0213934.

Research output: Contribution to journalArticle

Open Access
Nasopharyngeal Neoplasms
29 Citations (Scopus)

Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Apr 6 2019, In : The Lancet. 393, 10179, p. 1440-1452 13 p.

Research output: Contribution to journalArticle

Open Access
Breast Neoplasms
Drug Therapy
Appointments and Schedules

Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies

Cazzaniga, M. E., Verusio, C., Ciccarese, M., Fumagalli, A., Sartori, D., Valerio, M. R., Airoldi, M., Moretti, G., Ficorella, C., Gianni, L., Michelotti, A., Zambelli, A., Febbraro, A., Generali, D., Pistelli, M., Garrone, O., Musolino, A., Vici, P., Maur, M., Mentuccia, L. & 31 others, La Verde, N., Bianchi, G. V., Artale, S., Blasi, L., De Laurentiis, M., Atzori, F., Turletti, A., Porpiglia, M., Santini, D., Fabi, A., Gebbia, V., Schirone, A., Palumbo, R., Ferzi, A., Frassoldati, A., Scavelli, C., Clivio, L., Giordano, M., Donadio, M., Biganzoli, L., Del Mastro, L., Bisagni, G., Livi, L., Natoli, C., Montemurro, F., Riccardi, F., Romagnoli, E., Marchetti, P., Torri, V., Pronzato, P. & Mustacchi, G., Jan 1 2019, In : Breast Care.

Research output: Contribution to journalArticle

Extravehicular Activity
Breast Neoplasms
Aromatase Inhibitors
1 Citation (Scopus)
28 Citations (Scopus)